March 2024 | Dr. Robles challenges $70 million valuation, leading to settlement on favorable terms before start of trial.

Winter 2023 | Dr. Robles publishes article in Food and Drug Law Institute’s Update Magazine on desiderata for improving the FDA’s Accelerated Approval Program.

August 2023 | Dr. Robles publishes a Health Affairs Forefront article proposing a novel, economic solution to a central concern of the Accelerated Approval Program.

May 2023 | Dr. Robles publishes comment on “Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearances” in JAMA

March 2023 | Dr. Omar Robles gave a talk at the Harvard Kennedy School on “Recent and Future Federal Legislation to Control U.S. Drug Prices.”

November 2022 | Dr. Omar Robles gave a talk at the Harvard Kennedy School on “Innovation and Competition for Life-Saving Drugs.”

October 2022 | Emerging Health LLC hosted its first event of the season at the Greenwich Polo Club. The beauty, grace and athleticism of these Grand Prix horses is incredible. Thank you to those that attended. Looking forward to the next event.

May 2022 | Dr. Jonathan S. Olshaker joins Emerging Health LLC as an Affiliated Expert. Dr. Olshaker has nearly 20 years of experience as Chairman of the largest Level One trauma center in New England.

March 2022 | Introducing our first-of-its-kind guide to pharmaceutical industry terms.

January 2022 | Dr. James A. Feldman joins Emerging Health LLC as an Affiliated Expert. Dr. Feldman has over 40 years of experience in emergency medical care as a practicing physician and academic.

January 2022 | Have generic drugs been delayed or deterred from the marketplace by the Orphan Drug Act? Let’s start at the beginning.

November 2021 | Dr. Omar Robles gave a talk at the Harvard Kennedy School on “Innovation, Competition, and ‘Pay-for-Delay’ in Prescription Pharmaceuticals.”

October 2021 | Dr. Omar Robles gave a talk at the Harvard Kennedy School on “Regulating Drug Exclusivity in the Marketplace.”

October 2021 | Dr. Omar Robles gave a talk at the Harvard Kennedy School on “The Past, Present and Future of Drug Development.”

August 2021 | Dr. Kirk Moore joins Emerging Health LLC as an Affiliated Expert. Dr. Moore has a superb record of helping clients leverage data, machine learning, and economic modeling to develop actionable, strategic insights.

August 2021 | We examine years of data on citizens petitions to determine what impact they have had on FDA drug approvals.

July 2021 | Dr. Omar Robles honored with appointment at Harvard’s Mossavar-Rahmani Center for Business and Government for his expertise in prescription pharmaceutical competition.

June 2021 | The Orphan Drug Act is credited with increasing the number of orphan drug approvals. Does this mean there are more drugs that treat orphan diseases or more approved orphan designations per drug?

April 2024 | Dr. Robles’ research on harmonizing safety and speed in the regulation of 510(k) medical devices presented at the 34th POMS Conference.